Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab
Open Access
- 1 August 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (8) , 914-920
Abstract
Patients with unilateral neovascular AMD (nAMD) have considerable risk for conversion to choroidal neovascularization (CNV) in their fellow eye, with reported conversion rates of 12% to 22% at 2 years and 22% to 38.7% over 5 years.1-5 The largest study (to our knowledge) on the incidence of fellow eye conversion was the Age-Related Eye Disease Study (AREDS), in which 278 of 714 patients (38.9%) with unilateral nAMD experienced conversion to nAMD in their fellow eye over 6.3 years.6 While these prior reports provide important data for the general AMD population, data from large intravitreal anti–vascular endothelial growth factor (VEGF) treatment trials appear to show substantially higher nAMD conversion rates for patients, with unilateral nAMD ranging from 19% to 38% at 2 years.1,7Keywords
This publication has 25 references indexed in Scilit:
- Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated in the MARINA and ANCHOR TrialsAmerican Journal of Ophthalmology, 2010
- Risk Factors for Choroidal Neovascularization and Geographic Atrophy in the Complications of Age-Related Macular Degeneration Prevention TrialOphthalmology, 2008
- Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)Ophthalmology, 2007
- Pharmacokinetics of Intravitreal Bevacizumab (Avastin)Ophthalmology, 2007
- Fifteen-Year Cumulative Incidence of Age-Related Macular DegenerationOphthalmology, 2007
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyOphthalmology, 2006
- Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS)AREDS report no. 19Ophthalmology, 2005
- Five-year incidence of age-related maculopathy*1The Visual Impairment ProjectOphthalmology, 2004
- Indocyanine-green videoangiography of drusen as a possible predictive indicator of exudative maculopathyOphthalmology, 1998